$28.49
0.833%
Últ. Act.: Nov 6, 4:00 PM
Amphastar Pharma (AMPH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $1.14 | $0.85 | 34.1 % |
| Q2 | Aug 6, 2026 | $0.91 | $0.62 | 46.8 % |
| Q1 | May 7, 2026 | $0.42 | $0.69 | -39.1 % |
| Q4 | Feb 26, 2026 | $0.73 | $0.91 | -19.8 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $207.61M | $196.91M | 5.43 % |
| Q2 | Aug 6, 2026 | $183.90M | $180.36M | 1.97 % |
| Q1 | May 7, 2026 | $171.17M | $172.85M | -0.97 % |
| Q4 | Feb 26, 2026 | $183.11M | $191.70M | -4.48 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.85 | $0.62 | $0.69 | $0.91 |
| Actual | $1.14 | $0.91 | $0.42 | $0.73 |
| Surprise | +34.1% | +46.8% | -39.1% | -19.8% |
| Revenue | ||||
| Estimate | $196.9M | $180.4M | $172.9M | $191.7M |
| Actual | $207.6M | $183.9M | $171.2M | $183.1M |
| Surprise | +5.43% | +1.97% | -0.97% | -4.48% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.69 | $0.71 |
| Revenue | ||
| Consensus | $193.3M | $186.2M |